To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Assessing efficacy of an autologous protein solution injection versus saline for knee osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2018

Assessing efficacy of an autologous protein solution injection versus saline for knee osteoarthritis

Vol: 7| Issue: 2| Number:11| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:2

Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial

Am J Sports Med. 2018 Jan;46(1):171-180.

Contributing Authors:
L Engebretsen R Verdonk E Kon G Filardo S Nehrer

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

46 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized in a 2:1 fashion to intraarticular injection of either the Autologous Protein Solution blood product (nSTRIDE APS; Biomet Zimmer) or placebo saline. Patients were assessed for clinical measures and imaging results over a 12-month follow-up. For pain, the WOMAC pain score demonstrated favourable improvement in the A...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue